Literature DB >> 6431751

The effects of metformin compared to the effects of phenformin on the lactate production and the metabolism of isolated parenchymal rat liver cell.

O Jalling, C Olsen.   

Abstract

The metabolic effects of metformin were compared to the effects of phenformin on isolated parenchymal liver cells from fed and fasted rats with ethanol or glycerol as the only substrate. Both biguanides caused a fall in the hepatic oxygen-consumption, in the cellular ATP-content and in the ATP/ADP-ratio. The lactate production and the concentration-ratios of lactate/pyruvate and of beta-hydroxybutyrate/acetoacetate rose. The production rate of ketone bodies remained unchanged. This response was the same whether the hepatocytes were from fed or fasted rats and whether glycerol or ethanol was substrate. Only quantitative differences in the response on the biguanides were detected. The effects of the biguanides were dose dependent. Phenformin was ten times more potent than metformin. The same holds for their therapeutical potency. The findings indicate inhibition of the oxidative phosphorylation by both biguanides resulting in reduction of the cytoplasmic and the mitochondrial redox potentials causing enhanced lactate production. It is concluded that metformin excerts the same effects as phenformin on the hepatic metabolism, when the concentration ratio is about ten to one. Both biguanides give rise to elevated lactate production. This effect is highly increased when ethanol is present.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431751     DOI: 10.1111/j.1600-0773.1984.tb01938.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  7 in total

1.  Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio: a review of available literature.

Authors:  Daniel B Larach; W Andrew Kofke; Peter Le Roux
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

Review 2.  The effects of metformin on gut microbiota and the immune system as research frontiers.

Authors:  Michael Pollak
Journal:  Diabetologia       Date:  2017-08-02       Impact factor: 10.122

Review 3.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 4.  Metformin and metabolic diseases: a focus on hepatic aspects.

Authors:  Juan Zheng; Shih-Lung Woo; Xiang Hu; Rachel Botchlett; Lulu Chen; Yuqing Huo; Chaodong Wu
Journal:  Front Med       Date:  2015-02-12       Impact factor: 4.592

5.  Anti-diabetic biguanides inhibit hormone-induced intracellular Ca2+ concentration oscillations in rat hepatocytes.

Authors:  J J Ubl; S Chen; J W Stucki
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

6.  Diabetes mellitus carrying a mutation in the mitochondrial tRNA(Leu(UUR)) gene.

Authors:  M Kishimoto; M Hashiramoto; S Araki; Y Ishida; T Kazumi; E Kanda; M Kasuga
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

7.  Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells.

Authors:  A M Woollhead; J Sivagnanasundaram; K K Kalsi; V Pucovsky; L J Pellatt; J W Scott; K J Mustard; D G Hardie; D L Baines
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.